GNH USA

Europe — EMA

Indometacin Crescent Pharma

GNH USA supplies Indometacin Crescent Pharma (Indometacin), a nonsteroidal anti-inflammatory drug for rheumatoid arthritis, osteoarthritis, gout flares

Indometacin

Request sourcing

1
Pack/s

What is Indometacin?

Indometacin, the active ingredient in Indometacin Crescent Pharma, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is used to reduce inflammation and pain in conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout flares, and acute musculoskeletal pain.

GNH USA supplies Indometacin Crescent Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics across global distribution.

What is Indometacin used for?

Indometacin is indicated for several inflammatory and musculoskeletal disorders, acting primarily to control pain and swelling. - Rheumatoid arthritis: reduces joint inflammation and pain, helping maintain function. - Osteoarthritis: alleviates chronic joint pain and stiffness associated with degenerative changes. - Ankylosing spondylitis: diminishes spinal inflammation and discomfort, improving mobility. - Gout flares: provides rapid relief of acute gouty arthritis pain and swelling. - Acute musculoskeletal pain: lessens pain and inflammation in injuries or overuse conditions.

What are the side effects of Indometacin?

Indometacin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dyspepsia or stomach upset. - Headache. - Dizziness or vertigo. - Skin rash or mild itching.

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding. - Acute renal failure or worsening kidney function. - Severe hepatic injury or hepatitis. - Life‑threatening skin reactions such as Stevens‑Johnson syndrome or anaphylaxis.

What precautions apply to Indometacin?

When prescribing Indometacin, clinicians should consider several safety measures. - Renal function: monitor in patients with existing kidney disease. - Gastrointestinal risk: use the lowest effective dose and consider gastroprotective agents. - Cardiovascular: avoid in patients with uncontrolled hypertension or heart failure. - Pregnancy and lactation: safety not established; use only if benefits outweigh risks. - Drug interactions: review concomitant NSAIDs, anticoagulants, and antihypertensives. - Store at below 25°C: keep in the original container, protect from moisture and light.

What does Indometacin interact with?

Indometacin can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Lithium: elevated lithium serum concentrations. - Methotrexate: enhanced toxicity and reduced clearance.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible decline in renal function. - Diuretics: heightened risk of renal impairment. - Corticosteroids: increased likelihood of gastrointestinal ulceration.

Frequently asked questions

What conditions is Indometacin Crescent Pharma used to treat?+
Indometacin Crescent Pharma is prescribed for inflammatory and painful conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gout flares, and other acute musculoskeletal pains. It works by reducing inflammation and relieving pain, helping patients regain function and comfort.
How does indometacin work in the body?+
Indometacin belongs to the NSAID class and reversibly blocks the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes. By inhibiting these enzymes, it lowers the production of prostaglandins, which are chemicals that promote inflammation, pain, and fever. The reduction of prostaglandins leads to decreased swelling and discomfort.
What is the usual dose of Indometacin Crescent Pharma?+
The exact dose of Indometacin Crescent Pharma is determined by the prescribing clinician based on the patient’s specific condition, severity, age, and renal or hepatic function. Healthcare professionals tailor the regimen to achieve optimal therapeutic effect while minimizing risk.
Is Indometacin Crescent Pharma safe during pregnancy or breastfeeding?+
Safety data for indometacin in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.
How do I order Indometacin Crescent Pharma from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements), and required import documentation.
How does Indometacin compare with other NSAIDs?+
Indometacin is a potent NSAID with strong anti‑inflammatory activity, often considered more effective for gout flares compared with some other NSAIDs. However, it may have a higher incidence of gastrointestinal and renal side effects, so clinicians weigh its efficacy against safety profiles when selecting an alternative such as ibuprofen or naproxen.
What are the recommended storage conditions for Indometacin Crescent Pharma?+
Indometacin Crescent Pharma should be stored at temperatures below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability throughout its shelf life.
How is Indometacin Crescent Pharma administered?+
The medication is taken orally, usually with a full glass of water. It can be taken with food or milk to lessen stomach irritation, but patients should follow the specific instructions provided by their prescriber regarding timing and any dose adjustments.
What are the most serious risks associated with Indometacin Crescent Pharma?+
Serious risks include gastrointestinal ulceration or bleeding, acute kidney injury, severe liver dysfunction, and rare but life‑threatening skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored for signs of abdominal pain, blood in stool, sudden changes in urine output, jaundice, or rash, and seek medical attention promptly if they occur.
Who should not use Indometacin Crescent Pharma?+
Indometacin is contraindicated in individuals with known hypersensitivity to indometacin or other NSAIDs, those with active gastrointestinal bleeding or ulcer disease, severe renal or hepatic impairment, and patients in the third trimester of pregnancy. It should also be avoided in patients taking certain anticoagulants or lithium without close medical supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Indometacin
Route
Oral Use
Manufacturer
Crescent Pharma Limited
Origin
EU

Related products

Aliviosin

Aliviosin

Indometacin

Especialidades Farmacéuticas Centrum, S.A.
EU
Artrinovo

Artrinovo

Indometacin

Laboratorios Llorens, S.L.
EU
Artrinovo

Artrinovo

Indometacin

Laboratorios Llorens, S.L.
EU
Autritis

Autritis

Indometacin

Farma 1000 - Produtos Farmacêuticos, Lda.
EU